| Biomarker ID | 1697 |
| PMID | 26126436 |
| Year | 2015 |
| Biomarker | hsa-miR-518a |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: regulation of gene expression; nervous system development; regulation of RNA metabolic process; RNA biosynthetic process; gene expression |
| Experiment | Prostate Cancer Vs Benign prostatic hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | For discovery cohort, 48 Benign Prostatic Hyperplaisa BPH) patients with 70 PCa patients were considered. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p< 0.001 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | Values in regulatation column are presented as median (interquartile range; × 102 copies/miRNA concentration) |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |